REQUEST FOR EXPRESSION OF INTEREST (REoI) FOR PHARMACEUTICAL PRODUCTS REOI-AFG-2024-002 Closing date for receipt of REoI:  Multiple windows of submissions due on 1st day of every month open for 12 month starts on 1st July 2025 and ends on 1st May 2026. There are multiple due dates for submission: 1st of July 2025, 1st Aug 2025, 1st Sep 2025, 1st Oct 2025, 1st Nov 2025, 1st Dec 2025, 1st Jan 2026, 1st Feb 2026, 1st Mar 2026, 1st April 2026, 1st May 2026 and final due date 1st June 2026. UNICEF, Afghanistan Country Office, Kabul, Afghanistan is requesting Expressions of Interest from potential suppliers of pharmaceuticals from Afghanistan and its neighbouring countries (India, Iran, Pakistan, China, etc.) in preparation for a solicitation exercise for pharmaceutical products. Interested suppliers or manufacturers of pharmaceuticals, please read below the requirements and submit your expression of interest (EoI) by filling in the forms along with the documentation requested.   Purpose of the REOI:   This REoI is addressed to suppliers and manufacturers of pharmaceuticals in the region for the supply of any of the listed pharmaceutical products.   Description of requirements: S.No  Description 1  Aminophylline 100mg tablets 2  Amoxicillin 250mg dispersible tablet 3  Amoxicillin 500mg capsules 4  Amoxicillin 500mg tablets 5  Amoxicillin 125mg/5ml pwd.o.s./BOT-100ml 6  Amoxicillin powder for oral suspension, 250mg /5ml (anhydrous) 7  Ampicillin 1g (as sodium salt) powder for injection 8  Atenolol 100 mg tablets 9  Betamethasone 0.1% + Neomycine 0.5%, topical cream 10  Ceftriaxone powder for injection/infusion 500mg 11  Chlorhexidine 7.1 % umbilical gel tube 12  Chloroquine 50mg/5ml syrup 13  Ciprofloxacin 250mg tablet 14  Compound Sodium Lactate 1L bag 15  Diazepam 5mg/ml, injection 16  Diazepam Diazepam 5mg, tablet 17  Erythromycin (Ethyl succinate) Suspension 100 mg/ml, bottles 18  Ferrous sulphate 60mg tablets 19  Gentamicin eye drops 0.3% 20 Gentamicin 10mg/ml (as sulfate), injection 21  Gentamicin 20mg/ml (as sulfate), injection 22  Hydrocortisone pdr/inj 100mg 23  Iron 60 mg+ Folic Acid 400 mcg/ 24  Ketamine 50mg/ml (hydrochloride), injection 25  Lidocaine (hydrochloride) 1% + Adrenaline (epinephrine) 1:200 000, injection 26  Lidocaine (hydrochloride) 2% + Adrenaline (epinephrine) 1:200 000, injection 27  Metronidazole 400mg tablets 28  Micronutrient tabs, used during pregnancy 29  Nitrofurantoin 100mg, tablet 30  ORS fl.1Lx2+ Zinc 20mg 10tabs.kit/PAC 31  ORS low osm. flavour 20.5/1 32  Paracetamol 100mg disp. Tabs 33  Paracetamol 120mg/5ml o.s/BOT-60ml 34  Paracetamol 500mg tabs 35  Phenobarbital 100mg tabs 36  Phenobarbital 200mg/ml 37  Phenobarbital 15mg tabs 38  Phenoxymethylpenicillin (Penicillin V) 500mg (as potassium-salt), tablet 39  Phenoxymethylpenicillin (Penicillin V) 250mg (as potassium-salt), tablet 40  Salbutamol 2mg/5ml oral liquid/BOT-100ml 41  Salbutamol 4mg tablets 42  Salbutamol 5mg/2.5ml Neb sol. amp 43  Salbutamol inhalation (aerosol) 0.1 mg (sulfate) per dose, 200 doses/inhaler 44  Sodium Chloride 0.9 % w/v and Glucose 5% w/v solution 45  Sul.200mg+Trim.40mg/5ml or.sus/BOT-100ml 46  Sulf.100mg+Trimet.20mg disp.tab 47  Sulf.400mg+Trimet.80mg tabs 48  Suxamenthonium inj/50mg/ml/2ml 49  Tetracycline eye ointment 1%/TBE-5g 50  Tramadol 100mg/2ml, injection 51  Zinc 20 mg scored disp. Tablets   For an itemised list of products per category, please refer to the accompanying Expression of Interest (EoI) form.